<DOC>
	<DOCNO>NCT01837381</DOCNO>
	<brief_summary>The objective trial evaluate clinical outcome , treatment toxicity tumor response TEA unresectable HCC .</brief_summary>
	<brief_title>Transarterial Ethanol Ablation ( TEA ) Unresectable Hepatocellular Carcinoma ( HCC )</brief_title>
	<detailed_description>Transarterial therapy play important role treatment algorithm patient multifocal large intrahepatic lesion eligible surgical resection , transplantation , local ablative therapy . Among various option transarterial therapy include chemoembolization ( TACE ) , bland embolization , radioembolization , TEA , chemoembolization one proven survival benefit versus best supportive care randomize control trial . TEA hybrid bland embolization chemical ablation . Utilizing liquid agent Lipiodol-ethanol mixture consist 33 % ethanol volume , TEA offer complete long lasting embolization arteriole portal venule supply tumor could possibly effective particulate embolic agent tumor vessel embolization . The component ethanol likely offer synergistic effect embolization cause tumor ablation .</detailed_description>
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Carcinoma , Hepatocellular</mesh_term>
	<mesh_term>Ethanol</mesh_term>
	<criteria>Signed informed consent patient Age 18 year ChildPugh A B cirrhosis Eastern Cooperative Oncology Group ( ECOG ) performance score 2 No serious concurrent medical illness No prior treatment surgery HCC Histologically cytologically proven HCC except lesion size 1 2 cm , typical feature HCC two dynamic image technique , lesion large 2cm , typical feature one dynamic image technique , lesion large 2cm alpha feto protein ( AFP ) level &gt; 200 ng/mL Unresectable disease without extrahepatic involvement chest Xray ( CXR ) CT Massive expansive tumor type measurable lesion CT Total tumor mass &lt; 50 % liver volume Tumor size ≤ 15cm large dimension Tumor number ≤ 5 History prior malignancy except condition patient disease free ≥ 3 year Concurrent ischemic heart disease heart failure History acute tumor rupture present hemoperitoneum Serum creatinine level &gt; 180 umol/L Biliary obstruction amenable percutaneous drainage ChildPugh C cirrhosis History hepatic encephalopathy Intractable ascites controllable medical therapy History variceal bleeding within last 3 month ; serum total bilirubin level ≥ 50 umol/L Serum albumin level &lt; 25g/L International normalize ratio ( INR ) &gt; 1.5 Extrahepatic metastasis Infiltrative diffuse tumor Tumor number &gt; 5 Thrombosis target hepatic artery Partial complete thrombosis main portal vein ; tumor invasion portal branch contralateral lobe Hepatic vein tumor thrombus Significant arterioportal venous shunt Significant arterialhepatic venous shunt</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2016</verification_date>
</DOC>